Takeda Pharmaceutical
TAK
#434
Rank
ยฃ41.06 B
Marketcap
ยฃ13.00
Share price
1.78%
Change (1 day)
24.79%
Change (1 year)

EPS for Takeda Pharmaceutical (TAK)

EPS in 2025 (TTM): ยฃ0.42

According to Takeda Pharmaceutical's latest financial reports the company's current EPS (TTM) is ยฃ0.41. a decrease over its 2024 EPS that were of ยฃ0.22.

EPS history for Takeda Pharmaceutical from 2000 to 2025

Annual EPS

Year EPS Change
2025ยฃ0.17-25.03%
2024ยฃ0.22-60.3%
2023ยฃ0.5626.77%
2022ยฃ0.44-44.4%
2021ยฃ0.80722.5%
2020ยฃ0.09682-79.14%
2019ยฃ0.46-43.73%
2018ยฃ0.8270.24%
2017ยฃ0.4845.47%
2016ยฃ0.33-158.86%
2015-ยฃ0.57-217.99%
2014ยฃ0.48-34.43%
2013ยฃ0.735.17%
2012ยฃ0.70-49.61%
2011ยฃ1.38-6.27%
2010ยฃ1.4736.82%
2009ยฃ1.08-28.28%
2008ยฃ1.5024.96%
2007ยฃ1.209.24%
2006ยฃ1.103.21%
2005ยฃ1.07-6.29%
2004ยฃ1.1418.8%
2003ยฃ0.9630.39%
2002ยฃ0.7352.45%
2001ยฃ0.481.77%
2000ยฃ0.47

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
ยฃ7.65 1,759.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ5.39 1,211.28%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
ยฃ1.26 206.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ9.55 2,221.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ2.72 560.22%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
ยฃ5.56 1,252.93%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
ยฃ2.63 540.66%๐Ÿ‡ฌ๐Ÿ‡ง UK
Seagen
SGEN
-ยฃ2.94-814.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
ยฃ0.60 45.11%๐Ÿ‡ฎ๐Ÿ‡ณ India